Company profile: GenScript
1.1 - Company Overview
Company description
- Provider of contract research services specialized in biological research and drug discovery/development, offering gene synthesis with expression optimization, cloning and subcloning, plasmid DNA preparation for research, industrial and clinical applications, custom CRISPR-Cas9 gene editing, peptide synthesis, and ToxinSensor kits for sensitive, low-cost endotoxin detection.
Products and services
- Cloning and Subcloning: Engineers vector-based gene insertion for further study or application, performing initial cloning and subsequent subcloning into specified vectors
- CRISPR Services: Produces custom CRISPR-Cas9 gene editing to create specific gene modifications, offering custom, CRISPR-Cas9–guided edits for biological research
- Gene Synthesis: Architects synthetic genes based on customer specifications, including optimization for expression, delivering expression-optimized constructs supporting biological research and drug discovery
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to GenScript
BD Biosciences
HQ: United States
Website
- Description: Provider of flow cytometers; research cell analyzers and cell sorters; clinical cell analyzers; single-cell multiomics systems; and automated sample preparation systems for flow cytometry, supporting applications in immunology, cancer research, diagnostics, and clinical research.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BD Biosciences company profile →
Cube Biotech
HQ: Germany
Website
- Description: Provider of tools and services for membrane protein research, offering cell-free protein expression, synthetic polymer and MSP nanodiscs for stabilization and purification, ultrapure detergents, protein purification products (agarose and magnetic beads), and purified membrane proteins. Germany-based, operating a two-pillared model with service and product units.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cube Biotech company profile →
Spatial Transcriptomics
HQ: Sweden
Website
- Description: Provider of technology to perform RNA sequencing in 2D.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Spatial Transcriptomics company profile →
Definigen
HQ: United Kingdom
Website
- Description: Provider of in-vitro liver and metabolic disease models using iPSC technology to generate pre-clinical human data, offering Opti-HEPs for drug efficacy and predictive toxicology screening, phenotypic screening with bioassays, and custom disease model development via CRISPR. Includes models for Alpha-1 Antitrypsin Deficiency, Wilson's Disease (ATP7B), and Glycogen Storage Disease Type 1 Alpha.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Definigen company profile →
Avalon GloboCare
HQ: United States
Website
- Description: Provider of precision diagnostics and clinical lab services—including bloodwork, anatomic pathology, urine/drug toxicology, STAT blood and genetic testing, pharmacogenomic (PGx) testing via real-time PCR, and PCR COVID-19 testing—delivered via its Lab Services MSO. Also offers the FDA Class I KetoAir Breathalyzer for ketosis detection and the QTY protein design platform (joint IP with MIT) for water-soluble cytokine receptor variants.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Avalon GloboCare company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for GenScript
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to GenScript
2.2 - Growth funds investing in similar companies to GenScript
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for GenScript
4.2 - Public trading comparable groups for GenScript
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →